Sakar Healthcare Limited — QIP/Rights/Pref., 17-06-2025: Conversion

Sakar Healthcare has announced a board meeting to consider the financial results for the quarter and half-year. The company has allotted 3 lakh equity shares to non-promoter investors upon conversion of fully convertible warrants issued on a preferential basis at Rs. 384 per warrant. This follows a prior conversion of 2 lakh warrants. The total paid-up capital now stands at ₹22.25 Cr (2.22 crore shares of Rs. 10 each). Post allotment, no outstanding warrants remain. Non-promoter shareholding increased with the new equity infusion.